Optibiotix Health Plc: Industry told to cut sugar in cakes and chocolate by 20%

DirectorsTalk caught up with Optibiotix Health Plc (LON:OPTI) CEO Stephen OHara to comment on today’s news that sugar limits for everyday foods such as biscuits, chocolate bars and cereals have now been published by public health officials in a bid to make the UK’s children more healthy. Public Health England is challenging businesses to cut sugar by 20% by 2020, and by 5% this year. It says that the food industry should try lowering sugar levels, reducing product size or pushing healthier products.

So how will this be possible?

OptiBiotix Health Plc CEO Stephen OHara commented: “Today’s news of plans to reduce sugar in consumer products by 20%, and the previously announced sugar tax on soft drinks which comes into force next April, reflects Public Health needs to reduce sugar intake, particularly in children. OptiBiotix recognises the difficulties of changing consumer behaviour and is developing sweet natural healthy fibres called SweetBiotix® which are not digested in the human gut, and hence calorie free. This is an innovative concept which has the potential to address public health concerns over the impact of sugar on obesity, with the prospect of replacing ‘unhealthy’ sugars in existing products with non digestible, low calorie, healthy, SweetBiotix®’. Work to date has demonstrated our ability to synthesise SweetBiotix® with safety and sweetness confirmed by human taste studies. If we are able to sustain the rate of current progress we could be in a position to launch our first generation SweetBiotix®’s product later this year, or at the start of 2018’

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Optibiotix Health Plc

    More articles like this

    Optibiotix Health Plc

    NutraIngredients Awards shortlist announced

    NutraIngredients is pleased to announce the shortlisted finalists for the 2018 edition of the NutraIngredients Awards … with the winners announced at our exclusive awards evening in Geneva on 16th May. The shortlisted finalistsfor the 10

    Optibiotix Health Plc

    OptiBiotix Health plc Launch of Slimbiome® in Nutri-bites®

    OptiBiotix Health plc (LON:OPTI), a life sciences business developing compounds to tackle obesity, and high cholesterol, today announced the launch of its award winning SlimBiome® in Nutri-Bites® with its US partner, Cereal Ingredients (“CII”), at the 2018 Natural

    Optibiotix Health Plc

    OptiBiotix Health PLC OptiBiotix Capital Reorganisation

    OptiBiotix Health plc (LON:OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes announced on 28 November 2017 that it intended to seek a cancellation of its share premium account (the “Capital Reduction”) in

    Optibiotix Health Plc

    Optibiotix Health PLC In a Strong Position

    Optibiotix Health PLC (LON:OPTI) Chief Executive Officer Stephen O’Hara talks to tells Proactive Investors about focussing on the commercialisation of their technology across the company’s platforms.

    Optibiotix Health Plc

    Functional weight loss ingredient, SlimBiome brought to US

    OptiBiotix Health PLC (LON:OPTI), a specialist in the development of functional ingredients to modulate the human microbiome, has entered into a manufacturing and supply agreement with Cereal Ingredients. The agreement grants Cereal Ingredients a licence to

    Optibiotix Health Plc

    SlimBiome® – Supporting hunger-free weight management

    Slimbiome® is OptiBiotix’s patented combination of natural ingredients, identified and developed by leading experts in nutrition and metabolism, which supports scientifically substantiated weight loss claims. In independent tests the component ingredients have shown reductions in calorie intake

    Optibiotix Health Plc

    OptiBiotix Health PLC Proposed Directorate Changes

    OptiBiotix Health PLC (LON:OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, today announced that subject to the completion of normal regulatory due diligence Neil Davidson CBE will be appointed as Non- Executive Chairman on 1 January 2018. Adam Reynolds, the current Non-Executive Chairman will

    Optibiotix Health Plc

    Optibiotix Health PLC on Kelloggs’ Sugar Levels Cut

    Following the announcement today from Kelloggs to cut the amount of sugar in its three top selling children’s cereals, we caught up with Stephen O’Hara, CEO of OptiBiotix Health PLC (LON:OPTI) for his thoughts:   “We are really